SCHEMBL7867247

SCHEMBL7867247

Cc1[nH]c(=O)c(N(C)C2(c3ccccc3)CCC2)nc1CC(=O)NCCONC(=N)N

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 15/20 0.34
OPRM1 P35372 18/20 0.34
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876039 0.87 OPRL1 (0.31) OPRL1OPRM1
SCHEMBL3246131 0.77 F2 (0.43) OPRL1OPRM1
SCHEMBL7874308 0.76 AURKA (0.31)
SCHEMBL7878630 0.75 KDM4E (0.40)
SCHEMBL7867229 0.74 F2 (0.44)
SCHEMBL7876212 0.74 F2 (0.38)
Trifluoroacetic Acid SCHEMBL3238781 0.74 F2 (0.44) OPRL1OPRM1
SCHEMBL7874286 0.74 KDM4E (0.33)
SCHEMBL7878615 0.73 F2 (0.39) NPC1
SCHEMBL6426421 0.73 GBA1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1086122-A1 PYRAZINONE PROTEASE INHIBITORS Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (US) 2001-03-28 EP claimed
WO-1999064446-A1 PYRAZINONE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1999-12-16 WO claimed
EP-1086122-A1 PYRAZINONE PROTEASE INHIBITORS Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (US) 2001-03-28 EP disclosed
WO-1999064446-A1 PYRAZINONE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1999-12-16 WO disclosed